Myriad Genetics, Inc. (MYGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Myriad Genetics, Inc. (MYGN)

MYGN 6.480

+3.0%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (7)	1/24/1997 5:08:00 PM
From: Andrew G.	of 2355

Heny: 10 years! So why does Lehman put a $51/sh 12mo. target on MYGN ? Is this based on revenues or 10 year forward projection? Don't get me wrong. I think it's a wonderful discovery. It gives people hope that research is moving in the right direction. I just can't fathom this valuation of a company (near term) based on this finding. BTW MYGN finished up $36 +1.25 I see you are very knowledgeable about this subject and would like to introduce you to a truly novel approach to cancer that is being developed by a small company :(ticker: IGGI) see that SI thread. They have a patent pending carbohydrate compound that binds to lectins on cancer cells which prevents their adhesion and consequentialy deters metastasis. They recently gained FDA approval for testing on humans. I'd like to know what your thoughts are on it.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next